Sign Up Today and Learn More About iN Therapeutics Stock
Invest in or calculate the value of your shares in iN Therapeutics or other pre-IPO companies through EquityZen's platform.
![iN Therapeutics](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/enterbdfd_logo-ac9446a167041f1d.jpg)
iN Therapeutics Stock
iN Therapeutics is a biotechnology platform that develops new drugs for patients suffering from incurable neurological diseases.
About iN Therapeutics Stock
Founded
2020
Industries
Software, Data and Analytics, Artificial Intelligence
iN Therapeutics Press Mentions
Stay in the know about the latest news on iN Therapeutics
Cell Therapy Market Size to Grow At 22.67% CAGR Till 2033
biospace • May 23, 2024
Global Protein Expression Market Outlook 2024-2034: North America and APAC Set for Rapid Expansion
globenewswire • May 23, 2024
mRNA Therapeutics Market projected to reach USD 45.40 billion by 2030 with a 1.5% CAGR according to a new r...
whatech • May 23, 2024
Electrophysiological evaluation method for drug efficacy based on in vivo patch …
patents • Apr 15, 2024
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- iN Therapeutics current valuation
- iN Therapeutics stock price
- Available deals in iN Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in iN Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like iN Therapeutics through EquityZen funds. These investments are made available by existing iN Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell iN Therapeutics stock?
Shareholders can sell their iN Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."